Clinical Trial Update: Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV Treatment [Phase 3]

View source ↗

Summary

A Phase 3 trial update comparing ritonavir-boosted atazanavir with efavirenz as initial HIV therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• EFAVIRENZ (efavirenz)
• Ritonavir-boosted atazanavir (atazanavir/ritonavir)

Snippet

Sponsor: International Medical Center of Japan | Conditions: HIV Infection | Phase 3 | Status: COMPLETED